GE HealthCare today announced Allia platform upgrade pathways designed to help customers modernize select legacy Innova and Discovery Image Guiding Solutions (IGS) systems. These pathways provide access to Allia technologies and workflows that support efficiency and procedural decision-making while helping preserve existing infrastructure, avoid major construction work, extend interventional room lifetime, and minimize disruption to clinical operations.

As procedural complexity and patient volumes grow and installed systems age, healthcare providers are looking for flexible ways to modernize interventional environments. According to the European Coordination Committee of the Radiological, Electromedical and Healthcare IT Industry (COCIR), one-third of interventional X-ray systems in Europe are more than 10 years old, highlighting the importance of technology renewal planning.

Upgrade Capabilities

The upgrade pathways can help customers extend the value of existing systems through workflow enhancements, expanded interoperability capabilities and access to Allia innovations. Depending on system configuration, market availability and applicable regulatory requirements, upgrade options may provide access to capabilities and to third party solutions.

Strategic Value

"Interventional care continues to evolve rapidly, and health systems are looking for technology strategies that balance innovation, operational continuity and long-term value," said Jyoti Gera, CEO, CardioVascular and Interventional Solutions, Advanced Imaging Solutions, GE HealthCare. "These Allia upgrade pathways reflect our commitment to helping customers modernize on their own terms by extending the capabilities of existing systems while providing access to the latest Allia innovations and AI-enabled technologies in a less disruptive, more sustainable way."

GE HealthCare also provides Tube Watch and/or OnWatch Predict service options on all upgraded systems. These options help customers proactively manage system performance and maintenance by providing an AI-powered estimated lead time to failure, supporting efforts to reduce unplanned downtime. These upgrade pathways are available in the U.S. and other countries where Allia IGS and Allia IGS Pulse systems are available for sale.

RBC Capital analyst Shagun Singh has initiated coverage on GE HealthCare Techs with an Outperform rating and announced a price target of $80. The rating reflects a positive outlook on the company's performance potential.

Analyst Rating and Price Target

The initiation of coverage provides a new benchmark for investors evaluating GE HealthCare Techs. The Outperform rating suggests that the stock is expected to deliver above-average returns compared to the broader market.

The price target of $80 indicates the firm's projected valuation for the stock over the specified time horizon.